Landmark $9 Billion Verdict Delivered In Actos Bladder Cancer Lawsuit
10 April 2014No Comments
A Louisiana jury has returned a verdict in the first federal case involving Actos bladder cancer side effects, awarding $1.5 million in compensatory damages and another $9 billion in punitive damages against drug makers Takeda Pharmaceuticals and Eli Lilly. The jury award was delivered in an Actos lawsuit filed by Terrance Allen, who alleged that Takeda and Eli Lilly intentionally concealed information from consumers and medical professionals about the alleged link between Actos and bladder cancer side effects. If you have been diagnosed with bladder cancer, and you believe Actos to be the cause, consult our skilled Actos attorneys at Bandas Law Firm to discuss the possibility of filing a product liability lawsuit against Takeda Pharmaceuticals.
Takeda Accused of Concealing Actos Cancer Link
Allen’s Actos lawsuit was the first “bellwether” case to go to trial in the federal court system, where approximately 3,000 other Actos bladder cancer complaints are pending. Following more than 12 weeks of trial, the jury awarded $1.5 million in compensatory damages to compensate Allen for his bladder cancer injuries, and an additional $9 million in punitive damages, designed to punish Takeda and Eli Lilly for their deceptive actions. According to evidence presented during Terrance Allen’s trial, Takeda Pharmaceuticals actively tried to conceal the alleged connection between its Actos diabetes drug and bladder cancer side effects, and successfully did so for years.
Actos Bladder Cancer Lawsuits
Actos (pioglitazone) is a popular Type 2 diabetes drug used by millions of diabetes patients throughout the United States. In recent years however, serious concerns have been raised about the safety of Actos treatment, in light of evidence linking the drug to bladder cancer, and thousands of product liability lawsuits have been filed against Takeda as a result, albeit with conflicting outcomes.
- In May 2013, a California jury awarded $6.5 million in damages over Actos bladder cancer side effects, but the verdict was overturned after the state court judge excluded critical testimony in the case.
- A $1.77 million verdict delivered in September 2013 was also reversed when the jury found that the plaintiff failed to exercise reasonable care for his own health.
- A recent Actos bladder cancer trial resulted in a defense verdict after the jury found that the plaintiff’s bladder cancer was caused by a combination of Actos treatment and smoking.
Contact Our Actos Attorneys for Legal Help
Although Takeda maintained throughout this latest Actos trial that Allen’s bladder cancer wasn’t caused by the diabetes drug and that Takeda did due diligence in providing the public with bladder cancer warnings, the jury found that Allen’s use of the powerful diabetes medication is, in fact, what led to his bladder cancer diagnosis. If you took Actos in the past and you have since been diagnosed with bladder cancer or another serious side effect, contact our drug injury lawyers at Bandas Law Firm today for legal help. You may have grounds to file an Actos lawsuit against Takeda Pharmaceuticals, in order to pursue financial compensation for your injuries and medical bills.